Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects
Author:
Affiliation:
1. Centro de Referência Dona Libania, Brasil
2. Universidade Federal de Goiás, Brasil
3. Fundação Alfredo da Matta, Brasil
4. Universidade Estadual do Ceará, Brasil
5. Universidade Federal do Ceará, Brasil
6. Universidade de Brasília, Brasil
Publisher
FapUNIFESP (SciELO)
Subject
Microbiology (medical)
Link
http://www.scielo.br/pdf/mioc/v107s1/13.pdf
Reference24 articles.
1. Long-term efficacy of 2 year WHO multiple-drug therapy (MDT) multibacillary (MB) leprosy patients;Cellona RV;Int J Lepr Other Mycobact Dis,2003
2. Toxic effects and drug interactions of antimycobacterial therapy;Chan-Tompkins NH;Clin Dermatol,1995
3. Adverse effects of chemotherapeutic agents used in tropical medicine;Cook GC;Drug Saf,1995
4. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand: a prospective study, 1984-1996;Dasamanjali K;Int J Lepr Other Mycobact Dis,1997
5. Clofazimine and dapsone compliance in leprosy;Ellard GA;Lepr Rev,1988
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Causality, severity, and preventability of adverse drug reactions due to multi-drug therapy in leprosy: evidence from a national level institution in Sri Lanka;Leprosy Review;2023-06-01
2. A Change in the Trend of Quality Reporting in Leprosy Trials: A Systematic Review;Infectious Disorders - Drug Targets;2023-06
3. Effectiveness and safety of multidrug therapy containing clofazimine for paucibacillary leprosy and clarithromycin for rifampicin-resistant leprosy: a systematic review and meta-analysis;Frontiers in Medicine;2023-05-10
4. Alpha-Lipoic Acid and Its Enantiomers Prevent Methemoglobin Formation and DNA Damage Induced by Dapsone Hydroxylamine: Molecular Mechanism and Antioxidant Action;International Journal of Molecular Sciences;2022-12-21
5. Safer and newer antimicrobial drugs for leprosy – time to test monthly ROM in an adequately powered randomised trial?;Leprosy Review;2022-06-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3